Skip to main content
. 2022 Oct 24;42(3):903–915. doi: 10.1007/s10067-022-06417-3

Table 2.

Change in primary and secondary outcomes

Variable Telerehabilitation group (n = 24) Control group (n = 24) Differences in mean p value
Pre Post Mean differences Pre Post Mean differences
Painkillers in last 15 days 2.62 ± 2.90 0.20 ± 0.50 2.41 [(1.28)–(3.54)] 3.16 ± 3.14 2.66 ± 2.07 0.50 [(− 0.23) to (1.23)]  − 4.62 [(− 6.32) to (− 2.92)]  < 0.001
30 CST 10.29 ± 2.86 17.33 ± 1.12  − 7.04 [(− 8.10) to (5.91)] 10.66 ± 2.23 12.08 ± 2.32  − 1.41 [(− 2.13) to (0.70)] 5.25 [(4.18) − (6.31)]  < 0.001
NRS 5.25 ± 2.38 0.58 ± 1.50 4.66 [(3.68) − (5.64)] 5.58 ± 2.18 4.79 ± 2.51  − 1.75 [(− 2.73) to (− 0.76)]  − 3.83 [(− 5.10) to (2.56)]  < 0.001
KOOS
Symptoms 66.79 ± 17.69 87.62 ± 14.37  − 20.83 [(− 28.53) to (− 13.13)] 55.41 ± 25.81 62.87 ± 24.98  − 7.45 [(− 16.36) to (1.44)] 24.75 [(12.90) − (36.59)]  < 0.001
Pain 55.12 ± 20.90 87.62 ± 13.68  − 32.50 [(− 40.82) to (− 24.17)] 46.54 ± 22.71 56.66 ± 26.31  − 10.12 [(− 21.17) to (0.92)] 30.95 [(18.77)–(43.14)]  < 0.001
Functional status—daily living activities 59.87 ± 21.71 90.83 ± 12.48  − 30.95 [(− 39.93) to (21.98)] 49.54 ± 27.68 61.29 ± 27.66  − 11.75 [(− 23.35) to (− 0.14)] 29.54 [(17.07)–(42.01)]  < 0.001
Functional status—ports and leisure activities 32.50 ± 25.91 75.20 ± 21.39  − 42.70 [(− 52.33) to (33.08)] 36.25 ± 31.21 45.00 ± 32.90  − 8.75 [(− 19.24) to (1.74)] 30.20 [(14.08)–(46.33)]  < 0.001
Knee related QoL 39.87 ± 16.55 69.41 ± 18.90  − 29.54 [(− 35.99) to (23.09)] 40.75 ± 23.61 45.45 ± 24.38  − 4.70 [(− 14.16) to (4.74)] 23.95 [(11.28)–(36.63)]  < 0.001
Total 51.04 ± 17.89 82.00 ± 14.60  − 30.95 [(− 37.87) to (− 24.04)] 45.70 ± 24.27 54.33 ± 25.90  − 8.62 [(− 17.84) to (0.59)] 27.66 [(15.44)–(39.88)]  < 0.001
HADS
Anxiety 8.54 ± 3.92 4.29 ± 2.57 4.25 [(2.41)–(6.08)] 8.62 ± 3.60 6.91 ± 3.39 1.70 [(0.55)–(2.86)]  − 2.62 [(− 4.37) to (− 0.87)] 0.004
Depression 5.83 ± 2.88 2.70 ± 2.38 3.12 [(1.87)–(4.37)] 7.20 ± 3.17 5.41 ± 2.79 1.79 [(0.72)–(2.86)]  − 2.70 [(− 4.21) to (− 1.19)] 0.001
Total 14.37 ± 5.03 7.00 ± 4.07 7.37 [(4.88)–(9.86)] 15.83 ± 5.96 12.33 ± 5.66 3.58 [(1.97)–(5.19)]  − 5.33 [(− 8.20) to (− 2.46)] 0.001
TAMPA Kinesiophobia 41.58 ± 4.28 35.04 ± 6.51 6.54 [(3.34)–(9.74)] 44.08 ± 6.77 39.83 ± 5.18 4.25 [(1.00)–(7.49)]  − 4.79 [(− 8.21) to (1.36)] 0.007
FSS 5.07 ± 1.01 2.95 ± 1.28 2.11 [(1.56)–(2.66)] 5.26 ± 1.44 4.87 ± 1.16 0.39 [(− 0.08) to (0.86)]  − 1.91 [(− 2.62) to (− 1.20)]  < 0.001
IPAQ-SF, MET-min/week 569.25 ± 613.27 1225.58 ± 829.37  − 656.33 [(− 1067.17) to (− 245.48)] 647.14 ± 637.14 727.58 ± 360.75  − 183.66 [(− 450.93) to (83.60)] 394.77 [(19.05)–(770.48)] 0,040

30 CST 30-s chair stand test, NRS Numeric Rating Scale, KOOS Knee Injury and Osteoarthritis Outcomes Score, QoL quality of life, HADS Hospital Anxiety and Depression Scale, FSS Fatigue Severity Scale, IPAQ-SF International Physical Activity Questionnaire Short Form, MET metabolic equivalent, min minute